US2003135038A1PendingUtilityA1

Magnetic pigment

Assignee: ROCHE DIAGNOSTICS GMBHPriority: Jun 8, 1995Filed: Jul 23, 2002Published: Jul 17, 2003
Est. expiryJun 8, 2015(expired)· nominal 20-yr term from priority
C03C 3/089Y10S435/814C12N 15/1013C12Q 1/6834C03C 3/087C12Q 1/6804C03C 3/105Y10T428/2996C03C 3/111H01F 1/112H01F 1/36C03C 3/085C12Q 1/6806C07H 21/00C03C 3/091Y10S428/90C03C 3/102C03C 3/108H01F 1/0063C03C 3/083B03C 1/01B82Y 25/00C03C 3/078
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Magnetic particles with an outer glass surface being essentially poreless or having pores of a diameter of less then 10 nm as well as ferromagnetic particles with a glass surface are preferentially useful for the isolation of biological material from samples. They provide a quick and reliable purification.

Claims

exact text as granted — not AI-modified
1 . Magnetic particles with an outer surface made of glass that contains boroxide.  
     
     
         2 . Particles according to  claim 1 , characterized in that the glass surface is substantially pore-free or has pores with a diameter of less than 10 nm.  
     
     
         3 . Particles according to  claim 1  or  2 , characterized in that they have a particle size of between 10 and 60 μm.  
     
     
         4 . Particles according to  claim 1  or  2 , characterized in that any pores contained in the surface have a diameter of less than 1 nm.  
     
     
         5 . Particles according to  claim 1  or  2 , characterized in that the particles contain a composite material with a mica core and magnetite particles immobilized on it, the composite material being embedded in a glass layer.  
     
     
         6 . Procedure for isolating a biological material comprising 
 Bringing a sample that contains the biological material in a fluid in contact with particles according to one of the claims  1  through  15  under conditions in which the biological material binds directly to the glass surface, and    Separating the biological material from the fluid.    
     
     
         7 . Procedure according to  claim 6 , characterized in that the biological material is a nucleic acid.  
     
     
         8 . Procedure according to  claim 6  or  7 , characterized in that the magnetic particles are not premagnetized when brought in contact with the sample.  
     
     
         9 . Procedure for isolating nucleic acids comprising 
 Bringing a sample that contains the nucleic acids in native form in a fluid in contact with magnetic particles having glass surfaces that are substantially pore-free or that have pores with a diameter of less than 10 nm under conditions in which the nucleic acids in their native form can bind directly to the glass surface, and    Separating the bound nucleic acids from the fluid.    
     
     
         10 . Procedure based on  claim 9 , characterized in that the magnetic particles are not premagnetized when brought in contact with the sample.  
     
     
         11 . Procedure for manufacturing magnetic glass particles with a particle size of between 10 and 60 μm by 
 Providing a magnetic core and  
 Enclosing the magnetic core in a substantially pore-free glass surface by  
 Depositing a sol formed of an alcohol solution containing alkoxides of network-forming components on the surface,  
 Transforming the sol layer into a gel layer by means of a spray drying procedure, and then  
 Densifying the gel.  
 
     
     
         12 . Application of ferromagnetic particles having an outer glass surface that is substantially pore-free or has pores with a diameter of less than 10 nm for isolating nucleic acids in native form.

Join the waitlist — get patent alerts

Track US2003135038A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.